29 April 2020 Analysis
Central to the fight against Covid-19 is the clinical development of drugs, including novel compounds and those already approved for other indications. One way to support these efforts is through...
22 April 2020 News
New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19). Verdict has conducted a poll to assess which emerging technology among artificial intelligence (AI),...
2 April 2020 News
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s spike protein.
1 April 2020 News
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond Light Source and University of Oxford across the Atlantic...
31 March 2020 Analysis
AI has revolutionised healthcare by drastically reducing the time it takes to develop and commercialise a drug. Allie Nawrat talks to IQVIA’s technology solutions practice leader Updesh Dosanjh about the...
25 March 2020 Analysis
The reality of climate change is hard to ignore. As one of the biggest polluters, and simultaneously the industry tasked with trying to tackle the global health outcomes of environmental...
3 February 2020 Analysis
How will life sciences and healthcare have advanced by 2030? The Pistoia Alliance has published a report suggesting possible answers to this question, thereby helping companies and organisations decide where...
12 December 2019
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
11 December 2019 News
Flagship Pioneering has launched a new company, Cellarity, to discover drugs based on insights from research of cellular behaviours.